This company seems to have been delisted
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Orchard Therapeutics
ORTX
NZ$27.51
Share price
0.00%
Change (1 day)
246.74%
Change (1 year)
Orchard Therapeutics (ORTX) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : NZ$0.20 Billion
According to Orchard Therapeutics 's latest financial reports the company's total liabilities are NZ$0.20 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Orchard Therapeutics - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | NZ$0.19 B | 15.41% |
| 2021-12-31 | NZ$0.16 B | 15.9% |
| 2020-12-31 | NZ$0.14 B | -4.41% |
| 2019-12-31 | NZ$0.14 B | 82.23% |
| 2018-12-31 | NZ$81.55 M | 431.91% |
| 2017-12-31 | NZ$15.33 M | -48.96% |
| 2016-12-31 | NZ$30.03 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | NZ$1.46 B | 626.88% | Jersey |
 Novavax NVAX | NZ$2.25 B | 1,021.76% | 🇺🇸 USA |
 Organovo ONVO | NZ$6.84 M | -96.59% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | NZ$0.20 B | 0.00% | 🇬🇧 UK |